Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2003
02/06/2003US20030027301 Nucleotide sequences coding polypeptide for use in human therapeutics, diagnostics and pharmacogenomics
02/06/2003US20030027299 Biochemical conjugate for use in the treatment or prevention of stroke, heart defect, veinous thrombosis, sepsis and embolism
02/06/2003US20030027298 Enzyme mixture for use in the food processing, textiles treatment, paper making, pest control, wood prservatives and topical lotions
02/06/2003US20030027297 19 human secreted proteins
02/06/2003US20030027290 For producing glucose from starch
02/06/2003US20030027289 Kit for use in the generation of preferential expression vectors
02/06/2003US20030027287 Recombinant oleandolide polyketide synthase
02/06/2003US20030027286 Bacterial promoters and methods of use
02/06/2003US20030027285 Genetically engineered cells for use in the generation of fluorescent proteins
02/06/2003US20030027284 Tumor necrosis factor-gamma
02/06/2003US20030027283 Protein l and hybrid proteins thereof
02/06/2003US20030027281 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027261 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof
02/06/2003US20030027259 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's disease
02/06/2003US20030027257 Sequences for improving the efficiency of secretion of non-secreted protein from mammalian and insect cells
02/06/2003US20030027256 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumors
02/06/2003US20030027254 Nucleotide sequences coding protein for use in the treatment of alzheimer's disease
02/06/2003US20030027253 Nucleotides equences codin polypeptide for use in the treatment of cancer
02/06/2003US20030027252 Novel receptors
02/06/2003US20030027250 Methods and compositions for use in spliceosome mediated RNA trans-splicing
02/06/2003US20030027248 Human cDNAs and proteins and uses thereof
02/06/2003US20030027247 Antigen binding unit for use in human diagnostics and therapeutics
02/06/2003US20030027243 Screening or testing fungicide; obtain fungal protein sample, incubate with test modulator, monitor interaction between fungicide and protein, adjustment in protein activity indicate fungicide
02/06/2003US20030027241 For detection of bacteria based on recognition and infection of one or more selected strains of bacteria with bacteriophage genetically modified to cause production of an inducer molecule in the bacterium following phage infection
02/06/2003US20030027230 Detection of antiproliferative agents for treatment of ovarian cancer; obtain cells, incubate with modulator, monitor cells for reduction in cancer activity, reduction in cancer activity indicates antiproliferative agents
02/06/2003US20030027224 Monitoring immunosuppressive activity of compound; obtain sample containing calmodulin dependent kinase, incubate with substrate, expose to modulator, monitor phosphorylation, reduction in phosphorylation indicates suppressive activity
02/06/2003US20030027220 Chemical modification
02/06/2003US20030027210 Detecting modulator of plypeptide disassembly; obtain sample containing synuclein, incubate with modulator and thioflavin T, expose to probe, monitor reduction in aggregation by reduction in signal from probe
02/06/2003US20030027201 Method for mapping a nucleic acid
02/06/2003US20030027200 Biosensor for use in detection and measurement of preferential cellular activities
02/06/2003US20030027199 Measurement chip for biosensor
02/06/2003US20030027198 Nucleotide sequences coding polypeptide for use in the treatment of tumors
02/06/2003US20030027194 Modular assembly of nucleic acid-protein fusion multimers
02/06/2003US20030027192 Nucleotide sequences for use as tool in genetic engineering
02/06/2003US20030027189 Luminescent lanthanide metal chelate for use as tool in diagnostic analysis
02/06/2003US20030027188 SLC7s as modifiers of the p53 pathway and methods of use
02/06/2003US20030027184 Detection of preferential aptamer in sample; generate oligonucleotide, incubate with primer and polymerase, amplify and recover nucleotide sequences
02/06/2003US20030027183 Method of identifying a nucleic acid sequence in a plant
02/06/2003US20030027182 Method of determining the presence of a trait in a plant by transfecting a nucleic acid sequence of a donor plant into a different host plant in an anti-sense orientation
02/06/2003US20030027180 Rearrangement of nucleotide sequences; obtain nucleotide sequences, incubate with ligase, ligate, recover and analyze nucleotide sequence product
02/06/2003US20030027179 External control reagents for nucleic acid amplification
02/06/2003US20030027177 Human DNA mismatch repair proteins
02/06/2003US20030027175 Detection of gene sequences which generate preferential phenotypes; generate library of vectors, incubate with cells, transfect, screen for target phenotype, recover cells, determine sequence that generate preferential phenotype
02/06/2003US20030027173 Screening for preferential gene activity in plants; obtain plants, propagate, recover plants expressing preferential phenotype, propagate, transform with vector, screen for mutated gene
02/06/2003US20030027171 Polypeptide for use in the treatmet of cancer
02/06/2003US20030027170 Nucleotide sequence library for use as tool in genomic analysis
02/06/2003US20030027168 Generation of preferential nucleotide sequence; obtain complimentary nucleotide sequences, incubate with primers, amplify, recover nucleotide sequences
02/06/2003US20030027164 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
02/06/2003US20030027163 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027162 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027161 Human cDNAs and proteins and uses thereof
02/06/2003US20030027160 Terminal labeled probe array and method of making it
02/06/2003US20030027158 Novel nucleic acid sequences encoding human breast tumor-associated protein 47-like polypeptides
02/06/2003US20030027157 Determination of oncenntration of nucleotide sequences in sample; obtain sample, incubate with probe, detect signal, quantify nucleotide sequences
02/06/2003US20030027156 Generation of preferential proein; obtain nucleotide sequences, incubate with cells, transform cells, express nucleotide sequences, recover proteins
02/06/2003US20030027154 Nucleic acid arrays and method for detecting nucleic acids by using nucleic acid arrays
02/06/2003US20030027151 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of bone disorders
02/06/2003US20030027149 Generation of preferential probe for genome analysis; obtain solid support, incubate with target sequence and probe, detect signal, evaluate hybridization activity of probe
02/06/2003US20030027147 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
02/06/2003US20030027142 Novel genome analyzing method
02/06/2003US20030027135 Detection of parasite in sample; obtain sample containing parasite, extract nucleotide sequences from parasite, incubate with primer, amplify nucleotide sequences, determine molecular mass, compare to controls in libray of parasites
02/06/2003US20030027132 Secreted Protein HODAZ50
02/06/2003US20030027131 Expression of preferential protein in in culture; obtain cell, transfrom with vecro containg preferential protein, express vector, lyse cell, recover protein
02/06/2003US20030027130 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of viral diseases
02/06/2003US20030027127 Diagnostic kit for deection and classificaton of toxic compounds
02/06/2003US20030026857 Method of identifying pharmaceuticals from plant extracts
02/06/2003US20030026841 Compositions and methods for drug delivery using pH sensitive molecules
02/06/2003US20030026840 Immobilized into polyoxyethylene glycol
02/06/2003US20030026831 Complexes containing anions, cations and active materials
02/06/2003US20030026814 EIAV P26 deletion vaccine and diagnostic
02/06/2003US20030026810 Novel rhamnogalacturonan hydrolases
02/06/2003US20030026809 Stimulantion of immunological response
02/06/2003US20030026805 Genetic engineering; monoclonal antibody grafted to tumor necrosis factor
02/06/2003US20030026803 Compositions for inhibiting macrophage activity
02/06/2003US20030026800 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
02/06/2003US20030026796 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
02/06/2003US20030026795 Methods and compositions for controlling insects
02/06/2003US20030026793 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
02/06/2003US20030026792 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof
02/06/2003US20030026791 Aids therapy; insertion into cell a virus vector
02/06/2003US20030026789 Anticancer agents
02/06/2003US20030026785 Genetic engineering; activation; administering bacteriophages; side effect reduction
02/06/2003US20030026781 Compositions and methods for regulating endogenous inhibitor of ATP synthase, including treatment for diabetes
02/06/2003US20030026778 Chimeric cytokines and uses thereof
02/06/2003US20030026777 Detection and treatment of breast disease
02/06/2003US20030026737 Detecting, analyzing Dna
02/06/2003CA2857312A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using deoxyhypusine synthase (dhs)
02/06/2003CA2455722A1 Fermentation medium and method
02/06/2003CA2455681A1 An inducer of apoptosis
02/06/2003CA2455580A1 Multipotent stem cells from peripheral tissues and uses thereof
02/06/2003CA2455360A1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine
02/06/2003CA2454822A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using apoptosis-specific eif-5a
02/06/2003CA2454802A1 Novel class ii cytokine receptors and uses thereof
02/06/2003CA2454793A1 Transformation method for obtaining marker-free plants and plants obtained therewith
02/06/2003CA2454791A1 Antisense modulation of c-reactive protein expression
02/06/2003CA2454784A1 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques
02/06/2003CA2454701A1 Nucleic acid sequences encoding enantioselective amidases
02/06/2003CA2454570A1 Nanochannel arrays and their preparation and use for high throughput macromolecular analysis
02/06/2003CA2454469A1 Blood group antigen fusion polypeptides and methods of use thereof
02/06/2003CA2454415A1 Homogeneous assay of biopolymer binding by means of multiple measurements under varied conditions